Grace Therapeutics, Inc. (GRCE) insider trading.
In Q3 2026, insiders at Grace Therapeutics, Inc. reported 6 non-derivative transactions on 12 Forms 3, 4 and 5: 6 open-market purchases worth $302K and 0 sales.
- Transactions
- 6
- Purchases (P)
- 6
- Sales (S)
- 0
- Net shares, P minus S
- 141,926
- Insiders
- 2
- Last filed
- 2026-09-23
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Opaleye Management Inc. | TenPercentOwner | 5 | 5 | 0 |
| Kohli Prashant | Director, Officer · Chief Executive Officer | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Opaleye Management Inc. | P (A) | 5,318 | $2.1 | 2,855,318 | Form 4 |
| 2026-09-21 | Opaleye Management Inc. | P (A) | 9,771 | $2.1 | 2,850,000 | Form 4 |
| 2026-09-09 | Kohli Prashant | P (A) | 100,000 | $2.14 | 121,357 | Form 4 |
| 2026-09-09 | Opaleye Management Inc. | P (A) | 5,836 | $2.09 | 2,775,229 | Form 4 |
| 2026-09-08 | Opaleye Management Inc. | P (A) | 9,393 | $2.1 | 2,769,393 | Form 4 |
| 2026-08-14 | Opaleye Management Inc. | P (A) | 11,608 | $2.09 | 2,760,000 | Form 4 |
Transaction codes in this quarter
Get GRCE insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1444192&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · GRCE company page · Grace Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Grace Therapeutics, Inc. (GRCE)?
In Q3 2026, insiders at Grace Therapeutics, Inc. reported 6 non-derivative transactions on 12 Forms 3, 4 and 5: 6 open-market purchases worth $302K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Grace Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/grce.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.